Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.
There is now a large body of data indicating that the cannabinoid receptor type 2 (CB2) is linked to a variety of immune events. This functional relevance appears to be most salient in the course of inflammation, a process during which there is an increased number of receptors that are available for activation. Studies aimed at elucidating signal transduction events resulting from CB2 interaction with its native ligands, and of the role of exogenous cannabinoids in modulating this process, are providing novel insights into the role of CB2 in maintaining a homeostatic immune balance within the host. Furthermore, these studies suggest that the CB2 may serve as a selective molecular target for therapeutic manipulation of untoward immune responses, including those associated with a variety of neuropathies that exhibit a hyperinflammatory component.
Cabral
Guy A
GA
Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA. gacabral@vcu.edu
Griffin-Thomas
LaToya
L
D000595:Amino Acid Sequence; D000818:Animals; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D008969:Molecular Sequence Data; D009420:Nervous System / Q000276:immunology* / Q000473:pathology*; D015213:Neuroimmunomodulation / Q000502:physiology*; D043885:Receptor, Cannabinoid, CB2 / Q000737:chemistry / Q000276:immunology*; D012106:Research
D043885:Receptor, Cannabinoid, CB2